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Mm'ine epidermis contains PKC~" and r/as evidenced by the application of specific antisera, PKC( predominates in the cytosol and PKCr/in the 
particulate fraction, PKC~ is shown to be present also in other marine tissues, with large amoun:s found in lung. Whereas epidermal PKCr/i~ 
completely down-regulated by treatment of mouse skin '.~ith TPA or bryostatin 1 for 18 h, PKC~" is neither translocated by treatment with TPA 
for 20 rain, nor down.regulated by treatment with TPA or bryostatin 1 for 18 h, PKC~' is activated by phosphatidyl ~rine alone and does neither 
respond to Ca:* nor to TPA, It is inhibited by staurosporine with an ICso of 16 nM, which is within the same range of other PKC isoenzymen. 
The sensitivity of PKC~" towards the staurosporine derivative K252a is similar to that of PKCTfl,2" but much higher than that of PKC~ and ~. 
Murine epidermis; Protein kinase ~'; Protein kinase tl 
1. INTRODUCTION 
Protein kinace C (PKC) plays a key role in intracellu- 
lar signal transduction i  that it constitutes a link be- 
tween the receptor-mediated phosphatidylinositol and 
phosphatidylcholin breakdown and protein phospho- 
rylation (for a review see [1]). Today, PKC is known to 
cover a family of phospholipid-dependent isoenzymes 
catalyzing the phosphorylation f proteins at serine and 
thrcomine [1,2]. There are two classes of PKC isoen- 
zymes; one contains the putative Ca-'÷-binding region 
C-2 in the regulatory domain and is Ca-'~--responsive 
(PKS~,fl,7) and the other lacks this region and is Ca -'+- 
unresponsive (PKC&e,~',r/). cDNAs of all these isoen- 
zylnes were cloned and sequenced and the correspond- 
ing proteins were expressed in transfected cells (for a 
review see [2]). As the phorbol ester TPA is known to 
activate PKC, mimicking the physiological ctivator di- 
acylglycerol, PKC is thought o mediate TFA-induced 
biological effects including tumor promotion in mouse 
skin [1]. In this context, it is mandatory to know which 
PKC isoenzymes are present in mouse epidermis and 
which of these respond to TPA. PKCa,fl,7 [3] and pre- 
dominantly 8 [4,5] are expressed as protein in murine 
epidermis. The presence of PKC=.fl and & but not of 
PKC7 in murine epidermis was confirmed in terms of 
mRNA expression [6]. Our own unpublished ata indi- 
cate that murine epidermis lacks PKC2'. Human skin 
A bbreviations." PIKC, protein kina.se C; TPA, 12-O-tetradecanoylphor- 
bol-13-acetate; PS, phosphatidyl serine 
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also lacks this PKC isoenzyme [7]. Epidermal PKCa,fl 
[8] and 8 [4] were found to be down-regulated upon 
treatment of the skin with TPA. Recently, the expres- 
sion of PKCt /mRNA in mouse [6,9] and rat [10] skin 
was reported. Data on the expression of the respective 
protein in tissues are not available as yet. The same is 
true for PKC~'. 
Here we demonstrate by the use of specific antisera 
that PKCtl and ~" are present in mouse epidermis. 
Whereas PKCll predominated in the particulate frac- 
tion and, similar to other PKC isoenzymes, was down- 
regulated by TPA, PKC~" was mainly cytosolic and re. 
sistant o TPA with respect o translocation and down- 
regulation. 
2. MATERIALS AND METHODS 
2.1. Materials 
12-O-Tetradecanoylphorbol-13.acetate (TPA) and bryostatln I 
were kindly provided by Dr. E, H~.~ker. German Cancer R~rch  
Center, I-leidelber~g. Germany and Dr. G.R. Pet/it. State University of 
Arizona, Tempe, USA, respectively. [7,np]ATP (~p,~. act. 3000 Ci/ 
retool) was from DuPont-New England Nuclear (Waltham, Ma. 
USA). Protamine agarose, phosphatidyl serine and histone !11-$ were 
from Sigma, M unkh, Germany, Staurosporine was from Boehringer. 
Mannheim, German), and K252a from Fluka Chemic AG, Neu.Uim. 
Germany, 
2,2, Animals 
Female N M R I mice (7 weeks old) were used and fed a standard iet 
ad libitum, The back skin was shaved 3days before tr~tment witl~ 100 
pl acetone (control) or 10 nmol TPA or bryos';:atin I in acetone. 
2.3. PKC antL~'era 
PKC~" antiserum was obtained from Gibco BRL, Eggenstein. Ger- 
many. PKCa,fl.7 antiserum was prepared as described previously [4]. 
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Fig. 1. Immunological demonstration f PKC~" and r/in mouse pidermis. The shaved back skin of mice was treated with acetone (control, CON) 
or with 10 nmol "rPA or b~ostatin 1 (BRY) in acetone for 20 rain (A,C) or 18 h (B,D,E). Epidermal cytosols (C) and Triton X-100 extracts (TE) 
or particulate fractions were prepared and applied to protamine agarose as described in section 2. Protamine agarose luates (partially purified 
PKC preparations) or cytosol and extract directly (see IE) were used for immunoblotting with PKC~zfl,7 (C), PKCC (A,B) or PKCI1 (D,E) specific 
antisgra (seg section 2). A. lmmanoblotting of cytosols (C) and Triton X-100 extracts (TE) of particulate fractions alter protamine agarose 
chromatography, using the PKC~' antiserum. CON, control, TPA 20', after treatment with TPA for 20 rain. B. As in A, but after treatment with 
TPA or bryostatin 1for 18 h (TPA 18 h, BRY 18 h). C. As in A, but using the PKC~z,,a,? antiserum. D. As in B, but using the PKCt/antiserum. 
E. lmmunoblottinB ofcytosols (C) and Triton X-100 extracts (TE) o f particulate fractions (lanes 1-4) or protamine agarose luates of extracts (lanes 
5,6), using the PKCr/antiserum. 
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PKC~I antiserum was raised in rabbits against he oli8ol~ptlde 
INQDEFRNFSYVSPELQL that had an amino acid s~quen~e corre- 
sponding to the sequence 666-683 of PKCt/ [9], Immunization of 
rabbits was performed essenti~,lly as described previously [4], How- 
ever. the oligopeptide was used without coupling it to thyroglobulin. 
2,4, Prelmration of cytosol and particulttte extract fi'om various murine 
tissues 
Tissues were homogenized in buffer A (20 mM Tris.HCl, pH 7.5, 
10 mM fl-mercaptoethanol, 1 mM PMSF) using an Ultra-Turax ho- 
mogenizer, The homogenate was separated into cytosol and particu- 
late fi'action by centrifugation at 100,000 × g for 30 rain. Extraction 
of the particulate fraction was carried out with buffer B (20 mM 
Tris-HCl. pH 7.5, 5 mM EGTA, 2 mM EDTA. 1 mM PMSF, 0,2% 
Triton X-100. 10% glycerol) at 4°C for 30 mix. and ccntrifugation at
100.000 x g for 30 rain resulted in the particulate extract, 
2,5, Chromatography on protatnlne agarose 
2 to 3 ml (3 to 5 nag protein) of cytosol or particulate extract were 
appied to protamine-agarose column (1 × 0.8 era) equilibrated with 
buffer A, The column w~s washed with 4 ml buffer A COl~talninta 0.5 
M NaCI and elated with 2 ml buffer A containing 1.5 M NaCI. The 
eluate was either used directly for the PKC assay, or proteins in the 
eluate were precipitated with 10% triehloroaeetic a id and then used 
for immunoblottlng, 
2.6, htontmoblots 
Immunoblotting was perlbrmed essentially as described previously 
[11]. However, alkaline phosphatase.eonju~ated goat anti-rabbit ling 
was used for immunostaining [5], 
2,7, PKC assay 
The assay was performed as described previously [8], However. 
instead of purified PKC, 20 #1 of the protamine agarose luates of 
epidermal cytosol or particulate extract were used as enzyme prepara- 
tions. Ca ~'. PS and TPA were added as indicated in the text, 
3. RESULTS AND DISCUSSION 
A polyclonal antiserum raised against a PKC~" pep- 
tide was used to test mouse epidermis for the presence 
of PKC~'. A tissue homogenate was separated into cy- 
tosol and particulate fraction and the latter was ex- 
tracted with a buffer containing 0.2% Triton X-100. 
Chromatography of the cytosol and the particulate ex- 
tract on protamine agarose resulted in partially purified 
PKC preparations, which were used for immunoblot- 
ting. PKC~" was recognized by the antiserum and ap- 
peared in the immunoblot as a doublet with a molecular 
weight of around 80 to 82 kDa. It predominated in the 
cytosol. In addition, a third protein band corresponding 
to a molecular wei~,ht of 84 kDa was observed (Fig. IA 
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Fig, 2, lmmanoblotting of various tissue extracts using tl~e PKCr/ 
antiserum, Equal amounts of protein were applied to the gel. E. epi- 
dermis; S, spleen; L, lung; B, brain; P, pancreas. 
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Fig, 3, Dependence of PKC~ activity on various eofa~tors. Epidermal 
cytosol of TPA-treated (18 h) mouse skin was applied to protamine 
agarose -.nd the 1.5 M NaCl claate was used for determination f the 
PKC.~' activity with histone III-S as sub.~tra,e, 400/zM Ca'-', 350/Js/ml 
PS and I/~M TPA were added to the assay as indicated. Values are 
the mean of two determinations u ing different ¢ytosol preparations. 
The basal enzyme activity in the absence of any eofactor (100%) was 
1362 cpm and 1070 cpm in the two experiments. 
and 1B). The immunostaining ofall three protein bands, 
but not of the bands around 67 kDa, could be prevented 
by addition of the PKC~" peptide, which had been used 
to raise the antibody (.data not shown). A molecular 
weight of around 80 kDa was reported by Ways et al. 
[12] for PKC~" expressed in several cell types, including 
COS cells, transfected with a PKC~" eDNA. Quite simi- 
lar to our results, Wooten et al [13] observed in PCI2 
cells three protein bands in the 80 kDa range that were 
recognized by a PKC~' antibody. However, in the first 
report by Ono et al. [14] on PKC~" from COS ceils 
transfected with a PKC~" eDNA the enzyme showed a 
molecular weight of 64 kDa. This low molecular weight 
might have been due to a degraded form of PKC~'. 
Expression of the PKC~" protein was demonstrated in 
platelets [15] and in several cell types [12,13] but not in 
tissues so far. According to the data shown in Fig. 2, 
PKC~' appears to be rather an ubiquitous PKC isoen- 
zyme. It was found to be present, besides in epidermis, 
in all murine tissues tested, i.e. in spleen, lung, brain and 
Table I 
Inhibition of PKC~" by 5taurosporine and K252a (K252b) compared 
to other PKC isoenzymes. 
lsoen- IC~o(,aM) lC~, ~M) 
zyme Stauro- K252a 
sporine (K252b) 
lC~ isoermyme I 
ICon isoenzyme 2 
of K252a (K252b) 
0.009 i0 (2) h (1) h 50 250 
0.009 ~ (2)" (25) h [50] ~ 
~g,~" 0.007 0.2 (0,08) b f 
C 0.016 O,04 
'This value was taken from Koide et al. [19]. 
~Values in brackets represent inhibition by K252b and were taken 
from Koide et al. [19]. 
' This value represents a ratio of ICso values of K252b (6) and K252a 
(3  and therefore can be taken as a rough estimate only. 
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pancreas. Whereas lung contained the largest amounts 
of this isoenzyme, it was rather poorly represented in
brain. This is intriguing, since brain is a rich source for 
most of the other PKC isoenzymes. 
An antiserum raised in rabbits against a PKCr/-spe. 
cific peptide, with an amino acid sequence correspond- 
ing to the sequence 666 to 683 of PKC~I [9], recognized 
PKCtl selectively. None of the other isoenzymes 
(~,#,7,~,~,~ showed any reaction with this antiserum 
(data not shown). With the r/-specifie antiserum the 
presence of PKCr/could be demonstrated to some ex- 
tent in the cytosol, but predominantly in the particulate 
fraction of mouse epidermis (Fig. I D and E). It ap- 
peared in the immunoblot as a doublet with a molecular 
weight of around 86 kDa. Recently, Odasa et al [9] and 
Bather et al. [10] reported on the expression of PKCt/ 
(L-PKC) mRNA in mouse and rat skin, respectively. 
No data on the expression of the respective protein in 
skin and epidermis are available as yet. The molecular 
weight of 86 kDa is in accordance with that determined 
by Livneh and coworkers [10,16] for PKC~I expressed 
in transfeeted COS cells and in several other cell lines. 
Osada et al. [9], reported on a molecular weight of 82 
kDa for PKCr/expressed in transfected COS cells. Re- 
cently, a strictly nuclear localization of PKCr/ was 
found in various cell types [16]. Respective data on the 
cellular distribution of PKCr/in tissues have not been 
reported as yet. Even though we find PKCtl to predom- 
inate in the particulate fraction, preliminary data do not 
indicate a nuclear but rather a membrane localization. 
Treatment of mouse skin with TPA (10 nmol) for 20 
min caused a decrease of the amount of PKCg,,8 in the 
cytosol and an increase in the particulate fraction, i.e. 
a translocation of PKC0t,,8 from the cytosol to the par- 
ticulate fraction (Fig. IC). Contrary to PKC~,fl, the 
amount of PKC~" was not altered upon this treatment, 
neither in the cytosol nor in the particulate fraction 
(Fig. 1A). Thus, TPA did not induce translocation of 
PKC~'. Furthermore, treatment of mouse skin with 
TPA of bryostatin 1for 18 h did not cause down-regu- 
lation of PKC~" (Fig. 1B). In accordance with our find- 
ings in murine epidermis, Ways et al. [12] were also 
unable to cause translocation and down-regulation of
PKC~" by treatment of several cell types with TPA, and 
Huwiler et al. [17] found that PKC~" was not affected by 
phorbol-dibutyrate in rat renal mesangial cells. Crabos 
et al. [15], however, reported on a transiocation of 
PKC~" in human platelets upon treatment with TPA. 
Similar to PKC0t,fl [8] and PKCd [4], epidermal PKCrl 
was completely down-regulated bytreatment of mouse 
skin with TPA or bryostatin 1for 18 h (Fig. ID). Our 
finding of a TPA-induced own-regulation f PKCr/in 
murine epidermis was in contrast o a report of Greif 
et al. [16] on the lack of down-regulation f PKCr/in 
several cell types upon TPA-treatment. Therefore° the 
experiment was repeated with another group of ani- 
mals. Epidermal cytosol and particulate fraction as well 
100 
/30 I 
~ 4o  
..~ 20  ~e 
I i I 
10  100 1000 10000 
Inhibitor (riM) 
Fig. 4. Inhibition of PKC~" by staurosporine (I.n) and K252a (A-A). 
The same preparation f PKC~ as described in Fig. 3 was u~ed. The 
enzyme assay was performed in the presence of350/tg/ml PS and 
various concentrations f the inhibltor+ asindicated. 
as the particulate fraction after partial purification and 
concentration on protamine agarose were used for the 
immunoblot (Fig. I E). Again, complete down-regula- 
tion of PKCtl by TPA could be clearly demonstrated 
and was especially evident in the concentrated prepara- 
tion (Fig. 1 E, lanes 5 and 6). An immunostained protein 
in the cytosol, with a molecular weight slightly larger 
than that of the PKCt/doublet, was not down-regulated 
by the TPA or bryostatin 1treatment (Fig. 1D and E), 
suggesting it to be a cross-reacting protein different 
from PKCtl. As our data indicate that PKCr/in tissues 
behaves 'normally' compared to most other PKC isoen- 
zymes with respect to localization and down-regulation, 
the exclusive nuclear localization and the lack of down- 
regulation described by Greif et al. [16] is difficult to 
understand but might be due to a special property of 
PKCr] present in certain cell lines. Epidermal eytosol of 
TPA-treated (18h)mouse skin contained just PKC~', 
since all other PKC isoenzymes were down-regulated 
(see above). The lack of all PKC isoenzymes besides 
PKC~' was proved by immunoblotting of a respective 
cytosol using antisera specific for PKC0t,fl,7", PKC& 
PKCtl and PKC~" (data not shown). After partial purifi- 
cation of PKC~" from such a cytosol by chromatography 
on protamine agarose, we determined the activity of this 
isoenzyme with histone III-S as substrate (Fig. 3) and 
the inhibition of the enzyme activit:¢ by staurosporine 
and K252a (Fig. 4). As previously shown for PKC~" 
expressed in transfected COS cells [14], PKC~" exhibited 
a rather high basal activity (in the absence of any cofac- 
tor or activator), could be activated slightly by PS alone 
and was not further activated by the addition of Ca 2. 
or TPA to PS (Fig. 3). As long as PKC~" has not b~eti 
purified to homogeneity and the enzyme preparation 
might contain some other protein kinases, the actual 
basal activity of PKC~" and capacity of PS to activate 
the enzyme remains unknown. It seems evident from 
these results, however, that Ca 2÷ and TPA are unable 
to activate PKC~'. The inability of TPA to activate this 
154 
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PKC isoenzyme might be due to the lack of the second 
cystein-rich region in the regulatory domain of PKC~', 
as we had suggested previously [18]. Thus, PKC~" appar- 
ently does not respond to TPA at all, neither by activa- 
tion nor by translocation and down-regulation. PKC~" 
was inhibited by staurosporine with an IC50 of 16 nM 
and by K252a with an IC50 of 42 nM (Fig. 4). Thus, 
the inhibition of PKC( by staurosporine was compara- 
ble to that of other PKC isoenzymes ( ee Table 1). The 
staurosporinge d rivative K252a, however, differenti- 
ated between the isoenzymes, the inhibition of PKC~' 
being similar to that of PKCot,fl,?' but considerably 
more effective than that of PKCd and PKCe (see Table 
I). Data for PKCE [19] were obtained with K252b, a 
staurosporine d rivative very similar to K252a. 
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